Clinical Trials Logo

Pertussis Vaccine clinical trials

View clinical trials related to Pertussis Vaccine.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04494581 Completed - Pregnant Women Clinical Trials

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region

GriCoVax
Start date: May 3, 2019
Phase:
Study type: Observational

Implementation of organizational adjustments can enhance involvement of healthcare teams in carrying out flu and pertussis vaccinations, and optimizing access to vaccines for women and their families. Pertussis vaccination of pregnant women is envisaged by the French Health Autority, considering that, given international experiences, vaccination during the second trimester of pregnancy is safe, effective, and would aim to protect babies during the first months of their life. Before considering such a recommendation in France, the acceptability of this strategy by pregnant women and health professionals must be considered.